Cargando…

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure

Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunekuni, Kenta, Konno, Masamitsu, Haraguchi, Naotsugu, Koseki, Jun, Asai, Ayumu, Matsuoka, Kazuaki, Kobunai, Takashi, Takechi, Teiji, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795793/ https://www.ncbi.nlm.nih.gov/pubmed/31619711 http://dx.doi.org/10.1038/s41598-019-50968-6

Ejemplares similares

MicroRNA profiles involved in trifluridine resistance
por: Tsunekuni, Kenta, et al.
Publicado: (2017)

Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression
por: Matsuoka, Kazuaki, et al.
Publicado: (2018)

Theoretical analyses and experimental validation of the effects caused by the fluorinated substituent modification of DNA
por: Koseki, Jun, et al.
Publicado: (2020)

Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
por: Colvin, Hugh, et al.
Publicado: (2016)

Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells
por: Matsuoka, Kazuaki, et al.
Publicado: (2018)

Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts
por: Suzuki, Norihiko, et al.
Publicado: (2016)

Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018)

Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer
por: Nishizawa, Yujiro, et al.
Publicado: (2017)

Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2′-Deoxyuridine in Colorectal Cancer Cell Lines
por: Tsukihara, Hiroshi, et al.
Publicado: (2016)

Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
por: Takaoka, Yuji, et al.
Publicado: (2019)

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
por: Koseki, Jun, et al.
Publicado: (2018)

Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
por: Suzuki, Norihiko, et al.
Publicado: (2017)

Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
por: Suzuki, Norihiko, et al.
Publicado: (2021)

Hereditary pancreatitis model by blastocyst complementation in mouse
por: Asai, Ayumu, et al.
Publicado: (2020)

Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells
por: Konno, Masamitsu, et al.
Publicado: (2018)

Direct Analysis of Incorporation of an Anticancer Drug into DNA at Single-Molecule Resolution
por: Ohshiro, Takahito, et al.
Publicado: (2019)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

State-of-the-Art Technology of Model Organisms for Current Human Medicine
por: Konno, Masamitsu, et al.
Publicado: (2020)

Single-molecule RNA sequencing for simultaneous detection of m6A and 5mC
por: Ohshiro, Takahito, et al.
Publicado: (2021)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells
por: Koseki, Jun, et al.
Publicado: (2016)

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme
por: Brown, Daniel V., et al.
Publicado: (2015)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

BRAF(V600E) inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells
por: Sueda, Toshinori, et al.
Publicado: (2016)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

Computational analyses for cancer biology based on exhaustive experimental backgrounds
por: Koseki, Jun, et al.
Publicado: (2019)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells
por: Tamari, Keisuke, et al.
Publicado: (2018)

Computational healthcare: Present and future perspectives (Review)
por: Asai, Ayumu, et al.
Publicado: (2021)

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
por: Erhart, Friedrich, et al.
Publicado: (2018)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
por: Miyo, Masaaki, et al.
Publicado: (2016)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

Low expression of the GOPC is a poor prognostic marker in colorectal cancer
por: Ohara, Nobuyoshi, et al.
Publicado: (2017)

Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells
por: Yanagisawa, Kiminori, et al.
Publicado: (2020)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5h3u2pil6iq8uv1k54e458ru33